Molecule Structure

Scientific Name

Kanamycin

Description of the Drug

Kanamycin is an aminoglycoside antibiotic agent used in the treatment of various infections caused by susceptible bacteria.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01172

Brand Name(s)

Not Available

Company Owner(s)

Fresenius Kabi Usa Llc, Warner Chilcott Div Warner Lambert Co, Apothecon Inc Div Bristol Myers Squibb, Solopak Laboratories Inc, Watson Laboratories Inc, Pharmafair Inc, Loch Pharmaceuticals Inc, Abraxis Pharmaceutical Products, International Medication Systems Ltd, Hikma Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Bacterial 70S ribosome PROTEIN NUCLEIC-ACID COMPLEX INHIBITOR CHEMBL2363135

Unichem Links

SureChEMBL SCHEMBL2735
PharmGKB PA450137
Human Metabolome Database HMDB0015303
DrugBank DB01172
PubChem: Thomson Pharma 14785807 16090268
PubChem 6032
NMRShiftDB 60027773
LINCS LSM-5261
Nikkaji J4.492J
PDBe KAN
BindingDB 50031282
EPA CompTox Dashboard DTXSID3023184
DrugCentral 1519
Metabolights MTBLC17630
Brenda 229549 789 5165 229550
ChemicalBook CB2402286
rxnorm KANAMYCIN A SULFATE KANAMYCIN
KEGG Ligand C01822
ChEBI 17630
ZINC ZINC000008214590